Xilio Therapeutics Price Chart
Xilio Therapeutics Volume Chart
Xilio Therapeutics Market Segments
After Hours
+0.16(+1.93%)
| Open | $8.31 |
|---|---|
| Close | $8.47 |
| Low | $8.31 |
| Low Change | 0.00 (0.00%) |
| High | $8.47 |
| High Change | +0.16 (+1.93%) |
| Range | $0.16 |
| Volume | 761 |
| Dollar Volume | $6.45K |
Regular Trading Hours
+0.31(+3.89%)
| Open | $8.00 |
|---|---|
| Close | $8.31 |
| Low | $7.90 |
| Low Change | -0.10 (-1.25%) |
| High | $8.32 |
| High Change | +0.32 (+4.00%) |
| Range | $0.42 |
| Volume | 8.593K |
| Dollar Volume | $71.42K |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $7.99 |
|---|---|
| Close | $7.99 |
| Low | $7.99 |
| Low Change | 0.00 (0.00%) |
| High | $7.99 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 181 |
| Dollar Volume | $1.45K |
Regular Trading Hours Yesterday
+0.09(+1.14%)
| Open | $7.90 |
|---|---|
| Close | $7.99 |
| Low | $7.70 |
| Low Change | -0.20 (-2.58%) |
| High | $7.99 |
| High Change | +0.09 (+1.14%) |
| Range | $0.29 |
| Volume | 5.244K |
| Dollar Volume | $41.90K |
Premarket Yesterday
*No Trades in Segment
Xilio Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $7.86 |
|---|---|
| 10 Day Moving Average (SMA10) | $8.06 |
| 20 Day Moving Average (SMA20) | $8.25 |
| 50 Day Moving Average (SMA50) | $8.26 |
| 100 Day Moving Average (SMA100) | $5.31 |
| 200 Day Moving Average (SMA200) | $3.02 |
Xilio Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Xilio Therapeutics Stock Splits
There has been 1 stock split for Xilio Therapeutics (XLO). The reverse stock split occured on March 16, 2026 and reduced the outstanding shares at a ratio of 14:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 16, 2026 | Reverse | 14:1 |
Xilio Therapeutics Dividends
There have been no dividends for Xilio Therapeutics (XLO).